BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2020 9:17:13 AM | Browse: 659 | Download: 1429
 |
Received |
|
2020-05-23 06:45 |
|
Peer-Review Started |
|
2020-05-23 06:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-25 20:44 |
|
Revised |
|
2020-07-27 09:58 |
|
Second Decision |
|
2020-08-28 11:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-08-31 18:41 |
|
Articles in Press |
|
2020-08-31 18:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-09-09 02:42 |
|
Typeset the Manuscript |
|
2020-10-13 00:18 |
|
Publish the Manuscript Online |
|
2020-10-14 09:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Review |
| Article Title |
Type 1 diabetes mellitus and its oral tolerance therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rui-Feng Mao, Ying-Ying Chen, Ji Zhang, Xin Chang and Ye-Fu Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81803418 |
| Natural Science Foundation of the Jiangsu Higher Education Institutions |
18KJD350001 |
| Project for Youth Scholar of Jiangsu Collaborative Innovation Center of Regional Modern Agriculture and Environmental Projection |
HSXT2-314 |
|
| Corresponding Author |
Rui-Feng Mao, PhD, Research Scientist, Teacher, Jiangsu Collaborative Innovation Center of Regional Modern Agriculture and Environmental Protection, School of Life Science, Huaiyin Normal University, No. 111 Changjiang West Road, Huai'an 223300, Jiangsu Province, China. mmrf2008@163.com |
| Key Words |
Type 1 diabetes mellitus; Immunotherapy; Oral tolerance; Regulatory T cells; Antigen-specific immunotherapy; |
| Core Tip |
As an antigen-specific immunotherapy, oral tolerance therapy has shown promise as a new strategy for prevention and treatment of autoimmune diseases, including type 1 diabetes mellitus. Oral tolerance therapy in type 1 diabetes mellitus has been studied widely for a long time. In order to give a better understanding of these studies performed in animal models as well as in clinic, we review the related reports carefully and divide these studies into various categories based on their strategies. Based on the careful review, it may be useful to guide the future studies. |
| Publish Date |
2020-10-14 09:17 |
| Citation |
Mao RF, Chen YY, Zhang J, Chang X, Wang YF. Type 1 diabetes mellitus and its oral tolerance therapy. World J Diabetes 2020; 11(10): 400-415 |
| URL |
https://www.wjgnet.com/1948-9358/full/v11/i10/400.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v11.i10.400 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
